Farmahelis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,828,475 | 2,961,864 | 2,646,289 | 2,629,618 | 3,084,684 | 2,981,770 | 3,363,502 | 3,320,128 |
| Profit before tax | 220,189 | 128,899 | 101,018 | 18,934 | 120,048 | 68,840 | 366,232 | 285,579 |
| Net profit | 189,901 | 111,046 | 86,533 | 13,397 | 89,439 | 57,818 | 315,058 | 243,964 |
| Equity | 285,476 | 206,621 | 265,392 | 108,972 | 95,575 | 95,575 | 327,404 | 455,452 |
| Liabilities | 762,435 | 952,463 | 1,018,674 | 949,133 | 878,288 | 942,903 | 754,822 | 936,626 |
| Non-current assets | 73,203 | 69,055 | 53,363 | 39,839 | 28,122 | 37,101 | 23,622 | 14,611 |
| Current assets | 974,708 | 1,090,029 | 1,230,703 | 1,018,266 | 945,741 | 1,001,377 | 1,056,941 | 1,376,060 |
| Total assets | 1,047,911 | 1,159,084 | 1,284,066 | 1,058,105 | 973,863 | 1,038,478 | 1,080,563 | 1,390,671 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 363,408 | 402,527 | 400,927 |
| Social insurance contributions | - | - | - | - | - | 98,117 | 102,913 | 92,964 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +0.6% | +4.7% | -10.7% | -0.6% | +17.3% | -3.3% | +12.8% | -1.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 18.1% | 9.6% | 6.7% | 1.3% | 9.2% | 5.6% | 29.2% | 17.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 66.5% | 53.7% | 32.6% | 12.3% | 93.6% | 60.5% | 96.2% | 53.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 6.7% | 3.7% | 3.3% | 0.5% | 2.9% | 1.9% | 9.4% | 7.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.8% | 4.4% | 3.8% | 0.7% | 3.9% | 2.3% | 10.9% | 8.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.7 | 4.6 | 3.8 | 8.7 | 9.2 | 9.9 | 2.3 | 2.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 199,657 | 211,562 | 189,021 | 187,830 | 222,990 | 227,907 | 270,885 | 301,830 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Farmahelis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-02-19 | 2024-03-06 | 0.71 |
| 2024-01-23 | 2024-02-11 | 0.71 |
| 2023-10-17 | 2023-10-26 | 224.36 |
Farmahelis - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Farmahelis, UAB (code 134366564) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €3.32M, slightly below 2024 revenue of €3.36M, which indicates a mild year-on-year decline of 1.3%. Over the full two-year period, revenue still increased from €2.98M in 2023 to €3.32M in 2025. Profitability remained solid: net profit rose from €57.8K in 2023 to €315.1K in 2024, then eased to €244.0K in 2025, with a profit margin of 7.3% in the latest year. The balance sheet also strengthened, with total assets reaching €1.39M in 2025, equity at €455.5K and liabilities at €936.6K. Key ratios for 2025 show a return on equity of 53.6%, return on assets of 17.5%, debt-to-equity of 2.06, and asset turnover of 2.39x. Revenue per employee was €301.8K and profit per employee €22.2K, suggesting comparatively high productivity.